Abstract

We have previously shown that significant circadian oscillations exist for cardiac troponin T (cTnT) but not for cardiac troponin I (cTnI) (1). Cardiac myosin-binding protein C (cMyC) is a novel protein biomarker of myocardial injury with a promising role in the diagnosis and risk stratification of acute myocardial injury. In this study, we examine and compare the diurnal variation of cMyC with cTnT/I. Study design, population and methods are described by Klinkenberg et al. (1). Briefly, 26 consecutive hourly blood samples were drawn between 8.30 Am and 09.30 Am (+ 1 day) from 24 individuals without active cardiac disease, uncontrolled hypertension, anemia, renal dysfunction, or a history of acute myocardial infarction or stroke within 12 months. Seven percent had type 2 diabetes (all on oral blood glucose lowering medications) and 42% were on antihypertensive medication. cMyC was measured by Millipore Sigma (2). Limit of detection 0.4 ng/L, limit of quantitation (20% analytical coefficient of variation) of 1.2 ng/L; intra-series precision (CV, 11 +/− 3%), and inter-series precision (CV, 13 +/− 3%), 99th percentile is 87 ng/L. cTnT (Roche hs-cTnT) and cTnI (Abbott hs-cTnI) were measured previously by Klinkenberg et al. (1), but data were reanalyzed and are represented here to enable direct comparisons with cMyC.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call